IP Verse

Aera patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Aera

Explore patent oppositions filed by Aera against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 28, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3335707
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025
EP3934624
Topical Composition And Methods Of Measuring The Cooling Abaility Of A Topical CompositionFUTURA MEDICAL DEVELOPMENTSDec 9, 2024
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP3765024
Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor AntagonistsKANDY THERAPEUTICSAug 5, 2024
EP3448529
Medicated Hydrocolloid Dressing For Acne TreatmentPEACE OUTJul 16, 2024
EP3574907
An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent DiseasesKANDY THERAPEUTICSMay 23, 2024
EP2913327
Methylene Blue And Its Medical UsePROVENCEMar 7, 2024
EP3678649
Intranasal Epinephrine Formulations And Methods For The Treatment Of DiseaseAEGIS THERAPEUTICSJul 24, 2023
EP2981255
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023
EP2985026
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising SameBESINS HEALTHCARE LUXEMBOURGApr 26, 2023

Top competitors of Aera

Top competitors of Aera based on patent oppositions.